James Kirby Cunningham
Physician at Roscoe, Chicago, IL
License number
Colorado 18968
Issued Date
Oct 8, 1974
Renew Date
Dec 31, 1980
Expiration Date
Dec 31, 1980
Type
Physician
Address
Address
658 W Roscoe St W ROSCOE, Chicago, IL 60657
Professional information
Administrator &Amp; Customer Contact Expert
Position:
Administration at TechProcess Solutions Ltd
Location:
Greater Chicago Area
Industry:
Information Technology and Services
Work:
TechProcess Solutions Ltd
-
Administration
Education:
Northern Illinois University 1990 - 1994
Owner, Cunningham Group
Position:
Owner at Cunningham Group
Location:
Greater Chicago Area
Industry:
Insurance
Work:
Cunningham Group
-
Owner
James Cunningham - Chicago, IL
Work:
We Clean, Inc - Bridgeview, IL
Janitor Maintenance Associates Unlimited, Bethel Park, Illinois
Maintenance Associate Fairmont Hotel - Chicago, IL
Lobby Attendant KB Textile Mill - Chicago, IL
Warehouse Picker/Packer
Janitor Maintenance Associates Unlimited, Bethel Park, Illinois
Maintenance Associate Fairmont Hotel - Chicago, IL
Lobby Attendant KB Textile Mill - Chicago, IL
Warehouse Picker/Packer
Education:
Malcolm X College - Chicago, IL
Certificate in Basic Electronics Trainco Business School - Chicago, IL
Certificate in Business and Typing
Certificate in Basic Electronics Trainco Business School - Chicago, IL
Certificate in Business and Typing
Combination Therapy Including A Cyclooxygenase-2 Inhibitor And An Antineoplastic Agent
US Patent:
2005003, Feb 17, 2005
Filed:
Sep 20, 2004
Appl. No.:
10/945422
Inventors:
John McKearn - Glencoe MO, US
Gary Gordon - Highland IL, US
James Cunningham - Chicago IL, US
Stephen Gately - Palatine IL, US
Alane Koki - Beaufort MO, US
Jaime Masferrer - Ballwin MO, US
Gary Gordon - Highland IL, US
James Cunningham - Chicago IL, US
Stephen Gately - Palatine IL, US
Alane Koki - Beaufort MO, US
Jaime Masferrer - Ballwin MO, US
International Classification:
A61K031/7072, A61K031/704, A61K031/415, A61K033/24
US Classification:
424649000, 514027000, 514049000, 514283000, 514034000, 514406000, 514602000, 514559000, 514649000, 514492000, 514411000
Abstract:
The present invention provides methods to treat or prevent neoplasia disorders in a mammal using a combination of a cyclooxygenase-2 inhibitor and an antineoplastic agent.
Owner, Cunningham Group
Position:
Owner at Cunningham Group
Location:
Greater Chicago Area
Industry:
Insurance
Work:
Cunningham Group
-
Owner
Method Of Using An Integrin Antagonist And One Or More Antineoplastic Agents As A Combination Therapy In The Treatment Of Neoplasia
US Patent:
6833373, Dec 21, 2004
Filed:
Oct 5, 2001
Appl. No.:
09/857994
Inventors:
John P. McKearn - Glencoe MO
Gary Gordon - Highland IL
James J. Cunningham - Chicago IL
Stephen T. Gately - Palatine IL
Alane T. Koki - Beaufort MO
Jaime L. Masferrer - Ballwin MO
Gary Gordon - Highland IL
James J. Cunningham - Chicago IL
Stephen T. Gately - Palatine IL
Alane T. Koki - Beaufort MO
Jaime L. Masferrer - Ballwin MO
Assignee:
G.D. Searle Co. - Skokie IL
International Classification:
A61K 31505
US Classification:
514272, 514648
Abstract:
The present invention provides methods to treat or prevent neoplasia disorders in a mammal using a combination of an integrin antagonist and an antineoplastic agent.
Method Of Using An Integrin Antagonist And Radiation Therapy As Combination Therapy In The Treatment Of Neoplasia
US Patent:
6689787, Feb 10, 2004
Filed:
Oct 5, 2001
Appl. No.:
09/857871
Inventors:
John P. McKearn - Glencoe MO
Gary Gordon - Highland IL
James J. Cunningham - Chicago IL
Stephen T. Gately - Palatine IL
Alane T. Koki - Beaufort MO
Jaime L. Masferrer - Ballwin MO
Gary Gordon - Highland IL
James J. Cunningham - Chicago IL
Stephen T. Gately - Palatine IL
Alane T. Koki - Beaufort MO
Jaime L. Masferrer - Ballwin MO
Assignee:
G. D. Searle Co. - Skokie IL
International Classification:
A61K 31505
US Classification:
514275, 514398, 514352, 514300, 514299, 514183, 514395, 514565, 514538, 514397
Abstract:
The present invention provides methods to treat neoplasia disorders in a mammal using a combination of radiation and an integrin antagonist.
Method Of Using A Matrix Metalloproteinase Inhibitor And One Or More Antineoplastic Agents As A Combination Therapy In The Treatment Of Neoplasia
US Patent:
6858598, Feb 22, 2005
Filed:
Dec 22, 1999
Appl. No.:
09/857995
Inventors:
John P. McKearn - Glencoe MO, US
Gary Gordon - Highland IL, US
James J. Cunningham - Chicago IL, US
Stephen T. Gately - Palatine IL, US
Alane T. Koki - Beaufort MO, US
Jaime L. Masferrer - Ballwin MO, US
Gary Gordon - Highland IL, US
James J. Cunningham - Chicago IL, US
Stephen T. Gately - Palatine IL, US
Alane T. Koki - Beaufort MO, US
Jaime L. Masferrer - Ballwin MO, US
Assignee:
G. D. Searle & Co. - Chicago IL
International Classification:
A61K031/33, A61K031/445, C07D295/00, C07D211/00, C07D417/00
US Classification:
514183, 5142275, 5142278, 514283, 514318, 514319, 514321, 514330, 544 59, 544 60, 546 48, 546238, 546263
Abstract:
A method of using an MMP inhibitor and optionally radiation therapy, and one or more antineoplastic agents of the topoisomerase class selected from the group consisting of irinotecan and topotecan, as a combination therapy for the treatment of neoplasia is disclosed.
Method Of Using An Integrin Antagonist And One Or More Antineoplastic Agents As A Combination Therapy In The Treatment Of Neoplasia
US Patent:
2004023, Nov 25, 2004
Filed:
Jun 10, 2004
Appl. No.:
10/865414
Inventors:
John McKearn - Glencoe MO, US
Gary Gordon - Highland IL, US
James Cunningham - Chicago IL, US
Stephen Gately - Palatine IL, US
Alane Koki - Beaufort MO, US
Jaime Masferrer - Ballwin MO, US
Gary Gordon - Highland IL, US
James Cunningham - Chicago IL, US
Stephen Gately - Palatine IL, US
Alane Koki - Beaufort MO, US
Jaime Masferrer - Ballwin MO, US
International Classification:
A61K031/704, A61K031/7072, A61K031/445, A61K031/135
US Classification:
424/649000, 514/034000, 514/050000, 514/283000, 514/559000, 514/561000, 514/651000, 514/492000, 514/254070
Abstract:
The present invention provides methods to treat or prevent neoplasia disorders in a mammal using a combination of an integrin antagonist and an antineoplastic agent.
Antiangiogenic Combination Therapy For The Treatment Of Cancer
US Patent:
2002010, Aug 1, 2002
Filed:
Apr 25, 2001
Appl. No.:
09/843132
Inventors:
John McKearn - Wildwood MO, US
Gary Gordon - Highland Park IL, US
James Cunningham - Chicago IL, US
Stephen Gately - Palatine IL, US
Alane Koki - Beaufort MO, US
Jaime Masferrer - Ballwin MO, US
Gary Gordon - Highland Park IL, US
James Cunningham - Chicago IL, US
Stephen Gately - Palatine IL, US
Alane Koki - Beaufort MO, US
Jaime Masferrer - Ballwin MO, US
International Classification:
A61K031/706, A61K031/4745, A61K031/473, A61K031/407, A61K031/415, A61K031/277
US Classification:
514/043000, 514/283000, 514/297000, 514/410000, 424/450000, 514/406000, 514/521000
Abstract:
The present invention provides combinations of a DNA topoisomerase I inhibiting agent and a selective COX-2 inhibiting agent for preventing, treating, and/or reducing the risk of developing a neoplasia disorder in a mammal.